Evidence map›Paper›PMID 39233615›Full record

ArticleActa dermato-venereologica2024

Cutaneous Adverse Reactions to Apalutamide: Case Series with Clinical and Pathological Correlations.

Javier Gil-Lianes, Victoria Amat-Samaranch, Priscila Giavedoni, Antoni Vilaseca, Julián Córdoba Sánchez, Francesc Alamon-Reig, Paola Castillo, Adriana P Garcia, Mariona Pascal, Cristina Carrera

Abstract readCase Reports
In one paragraph

Article in Acta dermato-venereologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Javier Gil-LianesDepartment of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.
Victoria Amat-SamaranchDepartment of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain; Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain.
Priscila GiavedoniDepartment of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Barcelona, Spain.
Antoni VilasecaPharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Department of Urology, Hospital Clínic Barcelona, Barcelona, Spain.
Julián Córdoba SánchezDepartment of Urology, Hospital Clínic Barcelona, Barcelona, Spain.
Francesc Alamon-ReigDepartment of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Spain.
Paola CastilloDepartment of Pathology, Hospital Clínic Barcelona, Barcelona, Spain.
Adriana P GarciaDepartment of Pathology, Hospital Clínic Barcelona, Barcelona, Spain.
Mariona PascalPharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Department of Immunology, Hospital Clínic Barcelona, Barcelona, Spain.
Cristina CarreraDepartment of Dermatology, Hospital Clínic Barcelona, University of Barcelona, Spain; Pharmacovigilance program, Hospital Clínic Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red en Enfermedades Raras CIBERER, Instituto Salud Carlos III, Spain. ccarrera@clinic.cat.

Funding

Genetic Epidermiology of MelanomaR01CA083115 · NCI · UNIVERSITY OF PENNSYLVANIA · PI BISHOP, DAVID TIMOTHY, ELDER, DAVID ERIC · 2001 to 2017
$13.0M
NCI NIH HHS R01 CA083115
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Drug EruptionsThiohydantoinsAdultAgedBiopsyFemaleHumansMaleMiddle AgedSkinapalutamideThiohydantoins

Identifiers

PMID39233615
PMCPMC11382552

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.